Superficial erosion and the precision management of acute coronary syndromes: Not one-size-fits-all

European Heart Journal

Volumn 38, Issue 11, 2017, Pages 801-803

  Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CHEMOATTRACTANT; COLLAGEN; CYTOKINE; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ACUTE CORONARY SYNDROME; ARTERY INTIMA; ARTERY RUPTURE; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BLOOD CLOTTING; CORONARY STENTING; DEGRANULATION; EDITORIAL; EROSION; EXTRACELLULAR MATRIX; EXTRACELLULAR TRAP; HUMAN; INFLAMMATORY CELL; MACROPHAGE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS;

ACUTE CORONARY SYNDROME; HUMANS; PLAQUE, ATHEROSCLEROTIC; THROMBOSIS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 85018170791     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw599     Document Type: Editorial

References (18)

1. Saia F, Komukai K, Capodanno D, Sirbu V, Musumeci G, Boccuzzi G, Tarantini G, Fineschi M, Tumminello G, Bernelli C, Niccoli G, Coccato M, Bordoni B, Bezerra H, Biondi-Zoccai G, Virmani R, Guagliumi G; OCTAVIAI Investigators O. Eroded versus ruptured plaques at the culprit site of STEMI: in vivo pathophysiological features and response to primary PCI. JACC Cardiovasc Imaging 2015;8:566-575.
2. Kanwar SS, Stone GW, Singh M, Virmani R, Olin J, Akasaka T, Narula J. Acute coronary syndromes without coronary plaque rupture. Nat Rev Cardiol 2016;13:257-265.
3. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013;62:1748-1758.
4. Libby P. How does lipid lowering prevent coronary events? New insights from human imaging trials. Eur Heart J 2015;36:472-474.
5. Libby P, Pasterkamp G. Requiem for the 'vulnerable plaque'. Eur Heart J 2015;36:2984-7.
6. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013;368:2004-2013.
7. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 2015;36:1163-1170.
8. The Precision Medicine Initiative Program Working Group. The Precision Medicine Initiative Cohort Program-Building a Research Foundation for 21st Century Medicine. 2015.
9. Sato Y, Hatakeyama K, Yamashita A, Marutsuka K, Sumiyoshi A, Asada Y. Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart 2005;91:526-530.
10. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123: 2768-2776.
11. Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S, Tsironidou V, Giatromanolaki A, Skendros P, Konstantinides S, Ritis K. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J 2015;36:1405-1414.
12. Badimon L, Vilahur G. Neutrophil extracellular traps: A new source of tissue factor in atherothrombosis. Eur Heart J 2015;36:1364-1366.
13. Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging 2013;6:283-287.
14. Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, Xu M, Yao Y, Hu S, Yamamoto E, Lee H, Zhang S, Yu B, Jang IK. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J 2017;38:792-800.
15. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: A clinicopathological study. Circulation 2010;122:2505-2513.
16. Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BL. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb 2013;33:2032-2040.
17. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372:793-795.
18. Lyman GH, Moses HL. Biomarker tests for molecularly targeted therapies-the key to unlocking precision medicine. N Engl J Med 2016;375:4-6.